Home Medicine Evaluation of performance in preanalytical phase EQA: can laboratories mitigate common pitfalls?
Article
Licensed
Unlicensed Requires Authentication

Evaluation of performance in preanalytical phase EQA: can laboratories mitigate common pitfalls?

  • Anna Linko-Parvinen ORCID logo EMAIL logo , Jonna Pelanti ORCID logo , Tanja Vanhelo , Pia Eloranta and Hanna-Mari Pallari ORCID logo
Published/Copyright: December 16, 2024

Abstract

Objectives

Preanalytical phase is an elemental part of laboratory diagnostics, but is prone to humane errors. The aim of this study was to evaluate performance in preanalytical phase external quality assessment (EQA) cases. We also suggest preventive actions for risk mitigation.

Methods

We included 12 EQA rounds (Labquality Ltd.) with three patient cases (36 cases, 54–111 participants, 7–15 countries) published in 2018–2023. We graded performance according to percentage of correct responses in each case as ≥900 % excellent, 70–89 % good, 50–69 % satisfactory, 30–49 % fair and <30 % poor. Performance was simultaneously failed with ≥10 % of responses leading to harmful events.

Results

Overall performance was excellent in 7, good in 12, satisfactory in 10, fair in 4 and poor in 3 cases. Additionally, 7 cases showed failed performance. Routine requests with incorrect sample tubes or incorrect sample handling were detected with good performance. Lower performance was seen with sudden abnormal results, with rare requests, with false patient identification (never-events) and with incorrect test requests. Information technology (IT) solutions (preanalytical checklists, autoverification rules and patient specific notifications) could have prevented 33 of 36 preanalytical errors.

Conclusions

While most common errors were detected with good performance, samples with rare requests or those requiring individualised consideration are vulnerable to human misinterpretation. In many instances, samples with preanalytical errors should have been identified and rejected before reaching the laboratory or being directed to analysis. Optimising IT solutions to effectively detect these preanalytical errors allows for focus on infrequent events demanding accessible professional consultation. EQA preanalytical cases may help in education of correct actions in these occasions.


Corresponding author: Anna Linko-Parvinen, PhD, MD, Tyks Laboratories, Clinical Chemistry, Turku University Hospital, Kiinamyllynkatu 10, 20520, Turku, Finland; and Department of Clinical Chemistry, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland, E-mail:

  1. Research ethics: Not applicable.

  2. Informed consent: Not applicable.

  3. Author contributions: Anna Linko-Parvinen designed and produced the original study case contents, and wrote the primary draft of the manuscript including the data synthesis. Anna Linko-Parvinen and Hanna-Mari Pallari were resposible for case evaluation. Jonna Pelanti was responsible for gathering the data for all the study cases included in the study and provided detailed information regarding case responses. Tanja Vanhelo and Pia Eloranta were responsible for gathering the data in individual study cases. Hanna-Mari Pallari had significant contribution in data synthesis and manuscript draft writing. All authors participated in the manuscript drafting. The authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interests: Anna Linko-Parvinen has received rewards for the EQA rounds from Labquality (creation and review). She has not received any rewards regarding this publication. This publication is an independent retrospective study with a scientific purpose only. Jonna Pelanti, Tanja Vanhelo and Pia Eloranta are employees at Labquality. They have not received any rewards regarding this publication. This publication is an independent study with a scientific purpose only. Hanna-Mari Pallari states no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: EQA case descriptions are provided as Supplementary Material. Raw data, including response distribution and classificaation, is available upon request from the corresponding author.

References

1. Romero, A, Gómez-Salgado, J, Romero-Arana, A, Ortega-Moreno, M, Jódar-Sánchez, F, Ruiz-Frutos, C. Costs analysis of a training intervention for the reduction of preanalytical errors in primary care samples. Medicine 2020;99. https://doi.org/10.1097/md.0000000000021385. Available from: https://journals.lww.com/md-journal/fulltext/2020/07310/costs_analysis_of_a_training_intervention_for_the.59.aspx.Search in Google Scholar PubMed PubMed Central

2. Hjelmgren, H, Heintz, E, Ygge, BM, Andersson, N, Nordlund, B. Direct costs of blood drawings with pre-analytical errors in tertiary paediatric hospital care. PLoS One 2023;18. https://doi.org/10.1371/journal.pone.0290636.Search in Google Scholar PubMed PubMed Central

3. Mrazek, C, Lippi, G, Keppel, MH, Felder, TK, Oberkofler, H, Haschke-Becher, E, et al.. Errors within the total laboratory testing process, from test selection to medical decision-making – a review of causes, consequences, surveillance and solutions. Biochem Med 2020;30:020502. https://doi.org/10.11613/BM.2020.020502.Search in Google Scholar PubMed PubMed Central

4. Lippi, G, von Meyer, A, Cadamuro, J, Simundic, AM, for the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). PREDICT: a checklist for preventing preanalytical diagnostic errors in clinical trials. Clin Chem Lab Med 2020;58:518–26. https://doi.org/10.1515/cclm-2019-1089.Search in Google Scholar PubMed

5. Vermeersch, P, Frans, G, von Meyer, A, Costelloe, S, Lippi, G, Simundic, AM. How to meet ISO15189:2012 pre-analytical requirements in clinical laboratories? A consensus document by the EFLM WG-PRE. Clin Chem Lab Med 2021;59:1047–61. https://doi.org/10.1515/cclm-2020-1859.Search in Google Scholar PubMed

6. Simundic, AM, Cornes, M, Grankvist, K, Lippi, G, Nybo, M. Standardization of collection requirements for fasting samples: for the working group on preanalytical phase (WG-PA) of the European federation of clinical chemistry and laboratory medicine (EFLM). Clin Chim Acta 2014;432:33–7. https://doi.org/10.1016/j.cca.2013.11.008. Available from: https://www.sciencedirect.com/science/article/pii/S0009898113004464.Search in Google Scholar PubMed

7. Simundic, AM, Bölenius, K, Cadamuro, J, Church, S, Cornes, MP, van Dongen-Lases, EC, et al.. Joint EFLM-COLABIOCLI Recommendation for venous blood sampling. Clin Chem Lab Med 2018;56:2015–38. https://doi.org/10.1515/cclm-2018-0602.Search in Google Scholar PubMed

8. Lippi, G, Betsou, F, Cadamuro, J, Cornes, M, Fleischhacker, M, Fruekilde, P, et al.. Preanalytical challenges – time for solutions. Clin Chem Lab Med 2019;57:974–81. https://doi.org/10.1515/cclm-2018-1334.Search in Google Scholar PubMed

9. Cadamuro, J. Rise of the machines: the inevitable evolution of medicine and medical laboratories intertwining with artificial intelligence-A narrative review. Diagnostics 2021;11:1399. https://doi.org/10.3390/diagnostics11081399.Search in Google Scholar PubMed PubMed Central

10. Giavarina, D, Lippi, G. Blood venous sample collection: recommendations overview and a checklist to improve quality. Clin Biochem 2017;50:568–73. https://doi.org/10.1016/j.clinbiochem.2017.02.021.Search in Google Scholar PubMed

11. Cadamuro, J, Lippi, G, von Meyer, A, Ibarz, M, van Dongen-Lases, E, Cornes, M, et al.. European survey on preanalytical sample handling – Part 1: how do European laboratories monitor the preanalytical phase? On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE). Biochem Med 2019;29:020704. https://doi.org/10.11613/BM.2019.020704.Search in Google Scholar PubMed PubMed Central

12. Cadamuro, J, Lippi, G, von Meyer, A, Iibarz, M, van Dongen-Lases, E, Cornes, M, et al.. European survey on preanalytical sample handling – Part 2: practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE). Biochem Med 2019;29. https://doi.org/10.11613/bm.2019.020705.Search in Google Scholar PubMed PubMed Central

13. Cadamuro, J, Baird, G, Baumann, G, Bolenius, K, Cornes, M, Ibarz, M, et al.. Preanalytical quality improvement – an interdisciplinary journey. Clin Chem Lab Med 2022;60:662–8. https://doi.org/10.1515/cclm-2022-0117.Search in Google Scholar PubMed

14. Simundic, AM, Cornes, M, Grankvist, K, Lippi, G, Nybo, M, Kovalevskaya, S, et al.. Survey of national guidelines, education and training on phlebotomy in 28 European countries: an original report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PA). Clin Chem Lab Med 2013;51:1585–93. https://doi.org/10.1515/cclm-2013-0283.Search in Google Scholar PubMed

15. Grankvist, K, Sigthorsson, G, Kristensen, GB, Pelanti, J, Nybo, M. Status on fasting definition for blood sampling in the Nordic countries – time for a harmonized definition. Scand J Clin Lab Invest 2018;78:591–4. https://doi.org/10.1080/00365513.2018.1528503.Search in Google Scholar PubMed

16. von Meyer, A, Lippi, G, Simundic, AM, Cadamuro, J. Exact time of venous blood sample collection – an unresolved issue, on behalf of the European federation for clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE). Clin Chem Lab Med 2020;58:1655–62. https://doi.org/10.1515/cclm-2020-0273.Search in Google Scholar PubMed

17. Cadamuro, J, Simundic, AM. The preanalytical phase – from an instrument-centred to a patient-centred laboratory medicine. Clin Chem Lab Med 2023;61:732–40. https://doi.org/10.1515/cclm-2022-1036.Search in Google Scholar PubMed

18. Padoan, A, Plebani, M. Flowing through laboratory clinical data: the role of artificial intelligence and big data. Clin Chem Lab Med 2022;60:1875–80. https://doi.org/10.1515/cclm-2022-0653.Search in Google Scholar PubMed

19. van Dongen-Lases, EC, Cornes, MP, Grankvist, K, Ibarz, M, Kristensen, GBB, Lippi, G, et al.. Patient identification and tube labelling – a call for harmonisation. Clin Chem Lab Med 2016;54:1141–5. https://doi.org/10.1515/cclm-2015-1089.Search in Google Scholar PubMed

20. Lippi, G, Cadamuro, J, von Meyer, A. Simundic AM, on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Clin Chem Lab Med 2018;56:718–27. https://doi.org/10.1515/cclm-2017-1104.Search in Google Scholar PubMed

21. Coskun, A, Lippi, G. Personalized laboratory medicine in the digital health era: recent developments and future challenges. Clin Chem Lab Med 2024;62:402–9. https://doi.org/10.1515/cclm-2023-0808.Search in Google Scholar PubMed

22. Cadamuro, J, Carobene, A, Cabitza, F, Debeljak, Z, De Bruyne, S, van Doorn, W, et al.. A comprehensive survey of artificial intelligence adoption in European laboratory medicine: current utilization and prospects. Clin Chem Lab Med 2025;63:692–703. https://doi.org/10.1515/cclm-2024-1016.Search in Google Scholar PubMed

23. Padoan, A, Cadamuro, J, Frans, G, Cabitza, F, Tolios, A, De, BS, et al.. Data flow in clinical laboratories: could metadata and peridata bridge the gap to new AI-based applications? An investigation on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group on Artificial Intelligence (WG-AI). Clin Chem Lab Med 2025;63:684–91. https://doi.org/10.1515/cclm-2024-0971.Search in Google Scholar PubMed

24. Cadamuro, J. Disruption vs. evolution in laboratory medicine. Current challenges and possible strategies, making laboratories and the laboratory specialist profession fit for the future. Clin Chem Lab Med 2023;61:558–66. https://doi.org/10.1515/cclm-2022-0620.Search in Google Scholar PubMed

25. Lippi, G, Simundic, AM. On behalf of the European federation for clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE). The EFLM strategy Harmonization Preanalytical Phase 2018;56:1660–6. https://doi.org/10.1515/cclm-2017-0277.Search in Google Scholar PubMed

26. Cornes, MP, Church, S, van Dongen-Lases, E, Grankvist, K, Guimarães, JT, Ibarz, M, et al.. The role of European Federation of clinical chemistry and laboratory medicine working group for preanalytical phase in standardization and harmonization of the preanalytical phase in Europe. Ann Clin Biochem 2016;53:539–47. https://doi.org/10.1177/0004563216643969.Search in Google Scholar PubMed


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/cclm-2024-0990).


Received: 2024-08-25
Accepted: 2024-12-02
Published Online: 2024-12-16
Published in Print: 2025-04-28

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Are the benefits of External Quality Assessment (EQA) recognized beyond the echo chamber?
  4. Reviews
  5. Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part I – EQA in general and EQA programs in particular
  6. Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part II – EQA cycles
  7. Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part III – EQA samples
  8. Behind the scenes of EQA–characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part IV – Benefits for participant laboratories
  9. Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part V – Benefits for stakeholders other than participants
  10. Opinion Papers
  11. Not all biases are created equal: how to deal with bias on laboratory measurements
  12. Krebs von den Lungen-6 (KL-6) as a diagnostic and prognostic biomarker for non-neoplastic lung diseases
  13. General Clinical Chemistry and Laboratory Medicine
  14. Evaluation of performance in preanalytical phase EQA: can laboratories mitigate common pitfalls?
  15. Point-of-care testing improves care timeliness in the emergency department. A multicenter randomized clinical trial (study POCTUR)
  16. The different serum albumin assays influence calcium status in haemodialysis patients: a comparative study against free calcium as a reference method
  17. Measurement of 1,25-dihydroxyvitamin D in serum by LC-MS/MS compared to immunoassay reveals inconsistent agreement in paediatric samples
  18. Knowledge among clinical personnel on the impact of hemolysis using blood gas analyzers
  19. Quality indicators for urine sample contamination: can squamous epithelial cells and bacteria count be used to identify properly collected samples?
  20. Reference Values and Biological Variations
  21. Biological variation of cardiac biomarkers in athletes during an entire sport season
  22. Increased specificity of the “GFAP/UCH-L1” mTBI rule-out test by age dependent cut-offs
  23. Cancer Diagnostics
  24. An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors
  25. Cardiovascular Diseases
  26. Comparative evaluation of peptide vs. protein-based calibration for quantification of cardiac troponin I using ID-LC-MS/MS
  27. Infectious Diseases
  28. The potential role of leukocytes cell population data (CPD) for diagnosing sepsis in adult patients admitted to the intensive care unit
  29. Letters to the Editor
  30. Concentrations and agreement over 10 years with different assay versions and analyzers for troponin T and N-terminal pro-B-type natriuretic peptide
  31. Does blood tube filling influence the Athlete Biological Passport variables?
  32. Influence of data visualisations on laboratorians’ acceptance of method comparison studies
  33. An appeal for biological variation estimates in deep immunophenotyping
  34. Serum free light chains reference intervals for the Lebanese population
  35. Applying the likelihood ratio concept in external quality assessment for ANCA
  36. A promising new direct immunoassay for urinary free cortisol determination
Downloaded on 15.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2024-0990/html
Scroll to top button